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tional and administrative measures on the trend of use of uterotonics 
during delivery and puerperium. The study was conducted in the city 
of Novi Sad (350,000 inhabitants), Serbia, in 2012. The results were 
compared with the earlier data.1
Patients (or Materials) and Methods: All women giving the birth at 
Clinic of Gynecology and Obstetrics in Novi Sad during a 1- month 
period in 1988, 1999, 2007, and 2012 were included. Data about 
use of uterotonics during delivery and puerperium were recorded.
Results: The usage of ergot alkaloids for the induction of labor in 
1988 decreased from 54.7% in 1988 to 27% in 1999 after the train-
ing of doctors about the harmful effects of ergot alkaloids. Significant 
changes did not occur in 2007 (26.7%). After the decision of the 
Management of the Clinic of Gynecology and Obstetrics to decrease 
the use of ergot alkaloids for this indication, the reduction was 
recorded at 0.5% in 2012. At the same time, the use of oxytocin 
increased from 62.2% in 1988 to 93.5% in 2012. The use of ergot 
alkaloids for the prevention of the postpartum hemorrhage after the 
educational efforts decreased from 96.8% in 1988 to 9% in 1999. 
During the next 8 years, till 2007, it increased to 69.5% but after 
the the administrative measures, it was almost completely ceased to 
2.8% in 2012. The use of oxytocin decreased after the educational 
measures, whereas the administrative measures did not bring about 
any significant reduction for this indication.
Conclusion: Our results show the reduced usage of ergot alkaloids 
in the induction of labor, as well as in the treatment of postpartum 
hemorrhage as a result of educational and administrative measures. 
These findings are in accordance to the recommendations of the 
World Health Organization.
Funding Source: This work was supported by the Ministry of Science 
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Introduction: The appreciation of individual differences in the 
response to pharmacologic treatment has resulted in both exten-
sive research on various reasons for therapy failure and side effects, 
and in the introduction of therapeutic drug monitoring (TDM). The 
establishment of therapeutic levels requires large materials, and reli-
able information about exposure and symptoms. Similarly, making 
the diagnosis fatal drug intoxication as a cause of death remains a 
challenge for toxicologists and pathologists
Patients (or Materials) and Methods: In Sweden, nationwide data-
bases for forensic pathology and forensic toxicology have been in use 
since 1991. We have applied a strategy to select, review, and clas-
sify fatal intoxications and postmortem controls. This project also 
includes the compilation of analytical results obtained from driving 
under the influence cases, TDM cases, and from nonfatal intoxica-
tions. The situation is the same concerning these areas. There is cur-
rently no existing database, where such data are generally accessible 
and searchable.
Results: This strategy resulted in the publication of reference con-
centrations of 83 drugs in postmortem femoral blood. We have 
published an additional compilation focusing on antidepressant 
drugs, in which also relative toxicity index for the drugs studied are 
reported. We are currently reviewing additional groups of drugs 
according to the same protocol. An Internet database (Toxicolist) is 
already running, but it is not as yet made available for other users, 
since we still need to add data about additional drugs to make it 
interesting to wider groups. The database will offer search options 
so that each user can apply a search profile matching, for example, 
a case displaying particular circumstances and findings. At present, 
the database contains the results from > 15,000 postmortem cases, 
and several thousands of drugged driver cases as well as TDM results 
from patients.
Conclusion: Reference concentrations of blood drug levels are 
equally important as e.g. reference levels for various clinical chemis-
try tests of endogenous compounds. This information will improve 
the interpretation of forensic and clinical toxicology results, with 
impact on both medicolegal investigations and on death statistics. 
The levels in the TDM material are also important, particularly for 
a fair idea of whether a certain concentration is apparently elevated 
or implies therapeutic failure. The compilation of results will also 
allow for establishment of relative toxicity index for groups of drugs, 
for example, by comparing fatal and nonfatal intoxications with the 
number of detections and/or sales data. Such information can add 
to our knowledge view of the pharmaceutical profile of the drugs 
in question.
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Introduction: Yarrow (Achillea millefolium) means thousands leaves 
plant and belongs to the Asteraceae family. Yarrow is a gramineous 
perennial plant that grows in mountainous regions of Europe, North 
Africa, and East Asia (including North Iran and Alborz heights). This 
plant has many health benefits like treatingproblems of digestive 
system, respiratory system, cardiovascular system (stimulating blood 
circulation and lowering blood pressure), and genital-urinary system.
Patients (or Materials) and Methods: In this study, the effect of 
Yarrow extract was evaluated on immunity parameters of blood 
serum in little female laboratory rats (Balb/C race).At first, samples 
were divided randomly in 5 groups: 3 treatment groups, 1 control 
group, and 1 placebo group. Each group had 8 members, and all 
groups were kept in similar conditions. Hydroalcoholic extract 
was prepared in 3 doses including 50, 100, and 200 mg/kg and was 
injected in peritoneum every 2 days for 20 days. Normal saline was 
injected to placebo group. All measurements were done using protein 
electrophoresis method. Measured parameters were albumin amount, 
α -1 and α -2 globulin, β globulin, gamma globulin, albumin globulin 
ratio, and total protein.
Results: Results showed that the amount of albumin, β globulin, and 
total protein were increased in all 3 doses. α -2 were decreased in all 
treatments and α -1 were increased in all 3 doses but this increase 
was significant for doses 100 and 200 mg. Albumin globulin ratio 
was increased also in all treatments, but it was significant only for 
50 mg. Gamma globulin amount was increased in 50 and 100 mg 
but decreased a little in 200 mg.
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Conclusion: Results of this study showed that Yarrow extract caused 
significant changes in blood immune parameters and can affect 
immune system of body even in absence of antigenic factors.
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Introduction: In the United Kingdom, the self-administration of 
prescribed medicines by hospitalized patients has been supported by 
the Department of Health and pharmaceutical and nursing bodies. 
Suggested benefits of self-administration include improved patient 
knowledge about their medicines, improved concordance with treat-
ment, and increased patient satisfaction. We wished to assess the 
proportion of medicines administered by hospitalizd patients and 
to describe the patient and drug factors associated with self-admin-
istration.
Patients (or Materials) and Methods: We used data from University 
Hospitals Birmingham NHS Foundation Trust, which uses a locally 
developed electronic prescribing and medication administration sys-
tem known as PICS (Prescribing, Information and Communication 
System). We extracted data from every drug prescription and admin-
istration recorded from January 1, 2012, to December 31, 2012. The 
data were analyzed to ascertain the degree to which patients were 
self-administering in the hospital. Drug and patient data were also 
extracted to determine the association between these factors and 
self-administration.
Results: In the twelve-month period analyzed, 45,115 patients were 
admitted to hospital. During this time period, 657,230 drug prescrip-
tions were recorded, of which 5.8% (38,583) were administered by 
the patient at least once during the course of the prescription. The 
most commonly administered drugs were paracetamol, salbutamol, 
and nystatin. The majority of medicines (14,797; 38%) administered 
by the patient was in a tablet form. Almost two thirds (65.4%) of 
prescriptions identified as the patient’s own were administered by 
the patient.
Conclusion: Less than 6% of prescribed medicines were adminis-
tered by the patient over a 1-year period. These data will be used to 
focus the promotion of self-administration to appropriate patients. 
However, it remains unknown to what extent self-administration 
could or should be increased, as an evaluation of the benefits and 
potential harms of self-administration is required. Further work is 
also necessary to evaluate the role of electronic prescribing and medi-
cine administration systems in supporting the self-administration of 
medicines in patients where it is safe and appropriate.
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Introduction: Ready knowledge is knowledge that doctors should 
be able to recall in a clinical setting. Doctors need to have adequate 
ready knowledge of drugs they prescribe in daily clinical practice to 
be able to prescribe them appropriately, safely, and effectively. The 
aims of this study were: (1) to identify which aspects of a particular 
drug junior doctors should have as ready knowledge; and (2) to 
evaluate the level of their ready knowledge.
Patients (or Materials) and Methods: For 3 frequently prescribed 
drugs (amoxicillin, hydrochlorothiazide, diclofenac), a list of 
knowledge statements was compiled based on the Dutch Drug 
Compendium1. The statements were divided into 6 categories: drug 
class; mechanism of action; contraindications; side effects; interac-
tions; and method of administration (including dosage). To determine 
which knowledge of the 3 drugs is essential to good prescribing, 
a Delphi consensus study involving clinical experts was performed 
(1). The extent to which junior doctors meet these requirements was 
examined with a voluntary online assessment (2).
Results: (1)An average of 26 statements per drug were considered 
to be ready knowledge essential to good prescribing. The number of 
statements per category is described in the table. Knowledge about 
contraindications and method of administration comprise most of 
the essential ready knowledge. Other aspects include common side 
effects, basic mechanism of action, and standard adult dosage.
(2)Junior doctors’ overall level of the ready knowledge identified 
in (1) was 69.5% (mean % of maximum score). Junior doctors’ level 
of the ready knowledge per category is described in Table 1.
Table.  Number of statements and junior doctors’ level of total 
identified ready knowledge, per category (Junior doctors’ 
level: mean % of maximum score).
Category
Contra 
Indications
Method of 
Administra-
tion
Side  
Effects
Drug  
Class
Mechanism 
of Action
Intera - 
ctions
No. of 
statements
7 7 5 3 3 1
Junior 
doctors’ level
64.3% 62.5% 83.5% 86.7% 55.5% 75.7%
